The effects of trypsin on Escherichia coli cells that have been treated with colicins have been examined. By the use of trypsin, it has been possible to demonstrate that the action of several colicins (El, E2, and K) proceeds through at least two stages. Stage I is a period after colicin adsorption when trypsin can restore colonyforming ability to a colicin-treated cell./ Stage I is followed by a period when trypsin is unable to restore colony-forming ability (stage II). The transition between stage I and stage II follows first-order kinetics, with a rate proportional to the number of killing units of colicin adsorbed.
to the number of killing units of colicin adsorbed.
A quantitative comparison of the effects of colicin K on colony-forming ability and on several cellular processes indicates that colicin damage to these processes occurs in the stage II period of colicin action and is not subject to reversal by the trypsin treatment that restores viability to cells in stage I. The implications of these findings for an understanding of the mode of action of colicins are discussed.
The idea that colicins act from the surface of bacterial cells has arisen from reports that agents that presumably do not penetrate the outer membrane, such as trypsin (1) (2) (3) (4) or colicin-specific antiserum (5) , can reverse the effects of certain colicins. In the case of colicin K, it has been shown that some of the colicin-produced damage on Escherichia coli B cells can be repaired by prolonged exposure of colicin-treated cells to trypsin (1) . Other observations indicate that reversibility of the effects of colicin K by trypsin is limited. Wendt (6) has presented data indicating that trypsin completely reverses colicin K effects on colony-forming ability of E. coli K-12 only if the colicin treatment is performed at low temperatures (100 or lower). Barbu and his colleagues have proposed that trypsin rescues only those cells that colicin, although it has been adsorbed, has not yet damaged (7) (8) (9) .
To clarify this issue it is necessary to compare quantitatively the effects of trypsin on the colony-forming ability of colicintreated cells with the residual level of a colicin-inhibited function at the time of trypsin addition. A Leucine Incorporation. Cells (5 X 108/ml) were incubated in Ozeki medium supplemented with lactate, thiamine, and L-proline (100,ug/ml) for 10 min at 27°. [U-'4C]Leucine (100 uM; 10 Ci/mol) was then added and, at various time intervals, 0.2-ml aliquots were removed to tubes containing 1.0 ml of 10%o trichloroacetic acid in ice. The precipitates were collected on nitrocellulose filters and washed twice with 5.0-ml portions of cold 5% trichloroacetic acid; the filters were glued to planchets and counted. RESULTS Initially, we investigated the effects of trypsin on the loss of viability that results from treatment of an E. coli culture with colicin K. Culture samples were incubated with different amounts of colicin K for 5 min, and were then diluted 10-fold to stop or reduce further colicin adsorption. At various times after dilution, aliquots from the cultures were either plated directly to measure survival or were incubated with trypsin for 15 min before plating. An increase in the interval between adsorption of colicin K and addition of trypsin resulted in an exponential decrease in the proportion of Ktreated cells made viable by trypsin ( Fig. 1 ). Similar experiments with colicins El and E2 produced results fully compatible with those with colicin K. These findings indicate that after colicin adsorption, a period exists during which addition of trypsin can restore colony-forming ability to a colicin-treated cell. We designate this trypsin-rescuable period as stage I of colicin action, and the period that follows, when trypsin cannot restore viability, as stage II.
The results in Fig LA319 cultures (5 X 108/ml) were treated with the concentration of colicin K shown for 5 min at 270, and were then diluted 10-fold. Colicin K concentration is expressed as multiplicity (m), determined as described in Methods. At the times after colicin addition indicated, aliquots were either diluted and plated or incubated with trypsin (500 ,g/ml, 15 min, 270) before plating.
Survival was determined after overnight incubation of the plates at 370. To determine whether any functional damage to the cell has occurred in stage I of colicin K action, it is necessary to investigate the effects of trypsin on the inhibition of certain cellular functions by colicin K. If such functions can be inhibited by colicin K in stage I, trypsin addition should overcome the inhibition and restore some activity to the function measured. Therefore, we tested the ability of trypsin to reverse colicin K inhibition of the accumulation of #-galactosides (12) and of certain amino acids (13) , and its inhibition of protein synthesis (14) . The trypsin concentration used was 500 ,ug/ml, and the incubation time with trypsin was 15 min at 270. Control tests showed that survival of K-treated cells was maximal by 2 min after trypsin addition. Variation of the trypsin concentration between 200 and 1000 ug/ml did not significantly affect the results.
Colicin K, when added to a cell culture that has reached a steady-state level of TMGal accumulation, promptly causes a net efflux of the galactoside (Fig. 2) . Addition of trypsin stopped the TMGal efflux, but did not result in TMGal uptake to the original steady-state level. Instead, a new steadystate level was established, whose ratio to the control level corresponded closely to the fraction of cells that could still form colonies. When TMGal retention and colony-forming ability were followed as a function of the time of trypsin addition to the colicin-treated culture, it was found that the amount of TMGal retained and the colony-forming ability both decreased exponentially, and at the same rate (Fig. 3) . The rate of colicin K inhibition of TMGal uptake is shown in Fig. 4 (curve A) . At the colicin K multiplicity used, TMGai uptake continued at a decreasing rate for several minutes after colicin K addition. Only after the cells had been exposed Cells were incubated with [1 - to the colicin for 4 min was net loss of TMGal observed. Addition of trypsin stopped the further progression of colicin K effects on TMGal uptake, and resulted in the establishment of a steady-state level (curve B). This steady-state level was similar to that established by cells that had been treated with the same amount of colicin K for an equivalent period of time, and then exposed to trypsin before TMGal uptake was measured (curve C). If colicin K had an inhibitory effect on TMGal uptake in stage I, one would have expected some recovery in TMGal uptake after trypsin addition. No such recovery was evident. Moreover, the ratios of the steadystate level (40%) were quite similar to the fraction of colonyforming units that survived the colicin K-trypsin treatment (38%). This finding suggests that the colicin K effects on TMGal uptake occurred in stage II, coincident with the event that led to viability loss, and not during stage I.
From these results we conclude that during stage I of colicin K interaction with cells, the colicin has no detectable effect on the ability of the cells to accumulate TMGal. Rather, it appears that trypsin prevents colicin K from inhibiting TMGal uptake in cells by preventing the transition from stage I to stage II.
The effect of trypsin on colicin K-induced leucine efflux was similar to that obtained with TMGal; addition of trypsin during efflux resulted in the establishment of a steady-state level of leucine accumulation that was proportional to the residual fraction of viable cells ( Table 1) .
The effects of colicin K on leucine incorporation into protein are shown in Fig. 3 . Colicin K caused a progressive inhibition in the ability of a culture to incorporate leucine into protein. At the multiplicity used in the experiment presented, leucine incorporation into protein was completely inhibited only after the cells had been in contact with colicin K for 5-6 min. Addition of trypsin 4 min after colicin K prevented complete expression of the inhibitory potential of this colicin and resulted in a sustained residual rate of protein synthesis about 20% that of the control in this experiment. If At the time indicated, a portion of the cells from (A) was added to a tube containing sufficient trypsin solution to yield a final concentration of 500,gg/ml. Survival after a 15-min incubation with trypsin was 38%. (C) A portion of the cells in (A) was exposed to colicin K for 5 min, then trypsin and [1 -14C]TMGal were simultaneously added. Survival measured immediately before trypsin addition was 5%; survival measured after a 15-min incubation with trypsin was 38%. significant restoration of inhibited functions only after long periods of incubation with trypsin. A prerequisite for repair or reversal of colicin K-induced functional damage may be a prolonged exposure to trypsin, possibly to permit inactivation of the least accessible colicin molecules. Additional studies are being carried out to clarify this situation.
Nevertheless, the trypsin treatment used in our experiments has revealed that, in the early stages of colicin K action, there are two major classes of colicin-complexed cellsthose that at a given moment have not yet manifested physiological damage and can be rescued quantitatively by the trypsin treatment described and those that have sustained functional damage and cannot be rescued by the same trypsin treatment.
These findings agree with the proposal of Barbu and his colleagues (7) (8) (9) , and substantiate the hypothesis that the colicin-cell interaction goes through at least two successive stages: state I, in which the colicin adsorbs to the cell but does not cause any physiological damage; and stage II, in which the physiological damage occurs. Most adsorbed colicin molecules never reach stage II in their action. Those that do are the "killing units," or potentially damaging colicin molecules. Trypsin reduces the number of potentially damaging molecules on the cell to those that are already in stage II at the time of trypsin addition. Dandeu et al. (7) have suggested that the colicin-cell interaction eventually results in the colicintreated cell reaching a critical state that is unaffected by trypsin. This critical state would be the equivalent of what we have called stage II. Although it has been reported that repair of colicin E2-induced DNA damage follows early addition of trypsin (15), it has not been established that the repair results in restored viability to the E2-treated cells. This point is currently being investigated.
The second conclusion is that the transition from stage I to stage II follows first-order kinetics, with a rate proportional to the mean number of potentially damaging molecules per cell. Each potentially damaging molecule, therefore, has a constant probability per unit time of undergoing Cells were incubated with colicin K at 27°for the indicated times. Portions of the colicin-treated cells were then added to tubes containing sufficient trypsin solution to yield a final concentration of 500 /g/ml. After 15 min, the trypsin was inactivated by the addition of soybean trypsin inhibitor (250 Ag/ml final concentration). Control cells received no colicin K, but were carried through the trypsin incubation. [U-14C]Leucine was then added, and leucine uptake was measured. Little can definitively be said about either of the proposed stages I and II. Stage I probably represents the interval of the initial interaction between a colicin molecule and its specific receptor located in the E. coli outer membrane (17) . The spatial relationship between the bound colicin molecule in stage I and the components of the outer membrane must be such that at least certain critical regions of the colicin molecule remain accessible to the action of trypsin.
Stage II in colicin action results in cellular damage and loss of viability. The change in response to trypsin in stage II may mean either that the colicin is no longer readily accessible to trypsin, or that once stage II is reached it is maintained even in the absence of the intact colicin molecule. That the damage sustained in stage II of colicin K action is to the cytoplasmic membrane is suggested by the facts that certain transport systems are affected and that isolated membrane vesicles, as well as whole cells, respond to colicin K (18) . Since a single killing unit of colicin K in stage II can produce this damage, and since several killing units do not appear to act cooperatively (19) , some "spreading" mechanism must exist that distributes the initial effect to all of the systems ultimately affected. Such a mechanism could involve either conforma-tional changes (20, 21) or chemical modifications of the membrane. The latter possibility has some support in the phospholipid modifications observed after colicin treatment (22) . In the case of colicin K, the colicin itself may act enzymatically on the membrane, or it might activate or relocate one or more cellular enzymes, such as the phospholipase Al recently reported to be located in the E. coli outer membrane (23) . Recent evidence on the mode of action of colicins E2 (24) and E3 (25, 26) provides grounds for consideration of each of these possibilities for colicin K.
